SYNCHRONISE: LVO Triage Timing and Outcome Study

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

February 22, 2023

Study Completion Date

April 26, 2023

Conditions
Stroke, Ischemic
Interventions
DEVICE

Viz LVO (De Novo Number DEN170073)

"Viz LVO is a notification-only, parallel workflow tool for use by hospital networks and trained clinicians to identify and communicate images of specific patients to a specialist, independent of standard of care workflow.~Viz LVO uses an artificial intelligence algorithm to analyze images for findings suggestive of a pre-specified clinical condition and to notify an appropriate medical specialist of these findings in parallel to standard of care image interpretation. Identification of suspected findings is not for diagnostic use beyond notification. Specifically, the device analyzes CT angiogram images of the brain acquired in the acute setting and sends notifications to a neurovascular specialist that a suspected large vessel occlusion has been identified and recommends review of those images. Images can be previewed through a mobile application."

OTHER

Baseline Effectiveness Cohort

No Intervention was performed for the pre-Viz group. Record review to establish operational metrics only occurred.

Trial Locations (3)

30312

Wellstar Neurosurgery, Atlanta

38120

Semmes-Murphey, Memphis

78550

Valley Baptist Medical Center, Harlingen

All Listed Sponsors
lead

Viz.ai, Inc.

INDUSTRY

NCT04608617 - SYNCHRONISE: LVO Triage Timing and Outcome Study | Biotech Hunter | Biotech Hunter